We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+10.94%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$6.38B
AUM Growth
+$250M
Cap. Flow
-$95M
Cap. Flow %
-1.49%
Top 10 Hldgs %
24.3%
Holding
176
New
25
Increased
62
Reduced
40
Closed
19

Top Buys

Rank Stock Value
1
GTLB icon
GitLab
GTLB
+$45.6M
2
ROL icon
Rollins
ROL
+$37.7M
3
CPRT icon
Copart
CPRT
+$36.7M
4
MDB icon
MongoDB
MDB
+$36.7M
5
TTD icon
Trade Desk
TTD
+$36.6M

Top Sells

Rank Stock Value
1
CRWD icon
CrowdStrike
CRWD
+$76.4M
2
PANW icon
Palo Alto Networks
PANW
+$64.1M
3
KRTX
Karuna Therapeutics, Inc. Common Stock
KRTX
+$60.1M
4
LNG icon
Cheniere Energy
LNG
+$51.4M
5
APTV icon
Aptiv
APTV
+$43.1M

Sector Composition

Rank Sector Weight
1 Healthcare 38.57%
2 Technology 24.76%
3 Industrials 16.51%
4 Consumer Discretionary 8.57%
5 Communication Services 3.37%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
GPI icon
126
Group 1 Automotive
GPI
$3.42B
$9.7M 0.15%
33,194
+4,756
+17% +$1.3M
ANAB icon
127
AnaptysBio
ANAB
$1.58B
$9.62M 0.15%
427,000
– –
CBT icon
128
Cabot Corp
CBT
$4.54B
$9.42M 0.15%
102,159
+19,298
+23% +$1.57M
ARWR icon
129
Arrowhead Research
ARWR
$11.9B
$8.96M 0.14%
313,289
– –
TRML
130
DELISTED
Tourmaline Bio
TRML
$7.35M 0.12%
+320,916
New +$11.3M
SNV
131
DELISTED
Synovus
SNV
$6.96M 0.11%
173,794
+148,080
+576% +$5.57M
MGX icon
132
Metagenomi Therapeutics
MGX
$44.8M
$6.15M 0.1%
+583,041
New +$6.7M
SRE icon
133
Sempra
SRE
$57.9B
$5.64M 0.09%
78,488
-33,852
-30% -$2.43M
RLI icon
134
RLI Corp
RLI
$5.62B
$5.18M 0.08%
+69,730
New +$4.97M
RCUS icon
135
Arcus Biosciences
RCUS
$3.55B
$4.53M 0.07%
240,000
– –
PCOR icon
136
Procore
PCOR
$8.26B
$3.92M 0.06%
47,702
– –
LIN icon
137
Linde
LIN
$221B
$3.87M 0.06%
8,342
+3,768
+82% +$1.63M
PNFP icon
138
Pinnacle Financial Partners Inc
PNFP
$15.9B
$3.87M 0.06%
45,084
-35,757
-44% -$3M
SPGI icon
139
S&P Global
SPGI
$121B
$3.44M 0.05%
8,088
+3,880
+92% +$1.68M
TSM icon
140
TSMC
TSM
$2.1T
$3.29M 0.05%
24,160
+15,385
+175% +$1.91M
YARW
141
Yarrow Bioscience, Inc. Common Stock
YARW
$23.4M
$3.13M 0.05%
27,887
– –
AIP icon
142
Arteris
AIP
$1.38B
$2.92M 0.05%
399,023
– –
INTA icon
143
Intapp
INTA
$2.52B
$2.31M 0.04%
67,446
-18,590
-22% -$730K
NYAX
144
Nayax
NYAX
$2.55B
$2.29M 0.04%
+87,164
New +$2.2M
FIVN icon
145
CALL
FIVE9
FIVN
$2.11B
$2.24M 0.04%
+32,000
New +$2.22M
WM icon
146
Waste Management
WM
$90.6B
$1.7M 0.03%
+7,982
New +$1.57M
INTU icon
147
Intuit
INTU
$86.5B
$1.56M 0.02%
2,393
+419
+21% +$267K
AMGN icon
148
Amgen
AMGN
$208B
$1.39M 0.02%
+4,903
New +$1.43M
NVDA icon
149
NVIDIA
NVDA
$4.86T
$1.29M 0.02%
14,250
-1,370
-9% -$99.3K
NTNX icon
150
Nutanix
NTNX
$16B
$1.28M 0.02%
+20,670
New +$1.19M
4 5
6
7 8

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q1 2024 Portfolio in Review

As of Q1 2024, Eventide Asset Management held 176 positions worth $6.38B, up 4.1% from $6.13B the previous quarter. Its ten largest holdings account for 24% of the portfolio.

Eventide Asset Management's Q1 2024 filing shows 25 new, 62 increased, 40 reduced and 19 closed positions. Its largest new stake was GitLab: 695,704 shares worth $40.6M. The largest sale was CrowdStrike, an estimated $76.4M.

By sector, the portfolio is most concentrated in Healthcare at 39% of assets, down from 39% a quarter earlier, followed by Technology and Industrials.

  • Eventide Asset Management's largest Q1 2024 buy was GitLab: 695,704 shares worth $40.6M.
  • Eventide Asset Management added most to Rollins in Q1 2024, an estimated $37.7M increase.
  • Eventide Asset Management's biggest Q1 2024 reduction was CrowdStrike, cutting an estimated $76.4M.
  • Eventide Asset Management fully exited Karuna Therapeutics, Inc. Common Stock in Q1 2024, selling an estimated $60.1M.
  • Eventide Asset Management's ten largest holdings make up 24% of its $6.38B portfolio in Q1 2024.
  • Eventide Asset Management opened 25 new positions and closed 19 in Q1 2024.
  • Eventide Asset Management's portfolio value rose 4.1% quarter-over-quarter to $6.38B.

Based on Eventide Asset Management's 13F filing for Q1 2024, filed 15 May 2024.